Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.97% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.62% |
| 5 | Industrials | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
NeoGenomics
NEO
$2.09B
| $1.53M | ﹤0.01% |
87,699
-2,569,778
| -97% | -$36.6M |
|
3627
Choiceone Financial
COFS
$511M
| $1.52M | ﹤0.01% |
60,339
+17,023
| +39% | +$472K |
|
3628
Crinetics Pharmaceuticals
CRNX
$8.9B
| $1.52M | ﹤0.01% |
94,807
-480,681
| -84% | -$8.9M |
|
3629
QuinStreet
QNST
$1.2B
| $1.52M | ﹤0.01% |
95,621
+66,585
| +229% | +$1.05M |
|
3630
Theravance Biopharma
TBPH
$877M
| $1.52M | ﹤0.01% |
139,706
-535,784
| -79% | -$5.67M |
|
|
LTRPA
3631
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $1.52M | ﹤0.01% |
1,764,317
-1,086,007
| -38% | -$1.19M |
|
3632
Invesco S&P 500 Pure Value ETF
RPV
$1.68B
| $1.51M | ﹤0.01% |
19,965
+16,792
| +529% | +$1.36M |
|
3633
HNI Corp
HNI
$3.57B
| $1.51M | ﹤0.01% |
54,396
-33,184
| -38% | -$986K |
|
3634
Southern Missouri Bancorp
SMBC
$850M
| $1.51M | ﹤0.01% |
+40,464
| New | +$1.82M |
|
3635
PUT
Webster Financial
WBS
$12.8B
| $1.51M | ﹤0.01% |
+38,300
| New | +$1.84M |
|
3636
Stellus Capital Investment Corp
SCM
$246M
| $1.51M | ﹤0.01% |
+107,081
| New | +$1.55M |
|
3637
Prestige Consumer Healthcare
PBH
$2.6B
| $1.51M | ﹤0.01% |
24,077
+11,688
| +94% | +$730K |
|
3638
Vanguard Total International Bond ETF
BNDX
$82.2B
| $1.51M | ﹤0.01% |
30,786
+12,480
| +68% | +$605K |
|
|
3639
CALL
Webster Financial
WBS
$12.8B
| $1.51M | ﹤0.01% |
+38,200
| New | +$1.83M |
|
|
HCCI
3640
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $1.51M | ﹤0.01% |
+42,293
| New | +$1.52M |
|
|
NUVL
3641
DELISTED
Nuvalent
NUVL
| $1.5M | ﹤0.01% |
57,633
-159,523
| -73% | -$4.72M |
|
3642
MVB Financial
MVBF
$391M
| $1.5M | ﹤0.01% |
+72,786
| New | +$1.69M |
|
|
MRTX
3643
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.5M | ﹤0.01% |
40,400
+29,500
| +271% | +$1.33M |
|
3644
CALL
Adaptive Biotechnologies
ADPT
$3.9B
| $1.5M | ﹤0.01% |
+170,000
| New | +$1.5M |
|
|
PSTL
3645
Postal Realty Trust
PSTL
$698M
| $1.5M | ﹤0.01% |
98,347
+76,773
| +356% | +$1.15M |
|
|
FRC
3646
DELISTED
First Republic Bank
FRC
| $1.5M | ﹤0.01% |
106,834
-559,643
| -84% | -$57.4M |
|
3647
Coherus Oncology
CHRS
$210M
| $1.49M | ﹤0.01% |
218,474
-324,147
| -60% | -$2.52M |
|
|
SMMF
3648
DELISTED
Summit Financial Group, Inc.
SMMF
| $1.49M | ﹤0.01% |
71,872
+23,186
| +48% | +$565K |
|
3649
CALL
Boston Properties
BXP
$11.1B
| $1.49M | ﹤0.01% |
+27,500
| New | +$1.79M |
|
3650
Oak Valley Bancorp
OVLY
$278M
| $1.49M | ﹤0.01% |
62,871
+17,525
| +39% | +$444K |
|
Similar funds
Millennium Management's Q1 2023 Portfolio in Review
As of Q1 2023, Millennium Management held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Millennium Management withdrew a net $18.1B in Q1 2023, closing 1,209 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Warner Bros worth $96.9M.
- Millennium Management's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Millennium Management added most to Linde in Q1 2023, an estimated $374M increase.
- Millennium Management's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Millennium Management fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Millennium Management's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Millennium Management opened 987 new positions and closed 1,209 in Q1 2023.
- Millennium Management's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.